| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $73.2M | +11.7% |
| Cost of Revenue | $16.9M | +9.7% |
| Gross Profit | $56.3M | +12.3% |
| R&D Expense | $2.8M | -0.9% |
| SG&A Expense | $15.9M | +5.4% |
| Operating Income | $22.0M | +9.6% |
| Pre-tax Income | $24.3M | +11.7% |
| Income Tax | $5.0M | +10.9% |
| Net Income | $19.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.2M | +5.0% |
| Accounts Receivable | $10.6M | -13.6% |
| Inventory | $10.4M | -18.9% |
| Current Assets | $75.2M | -1.0% |
| Total Assets | $98.3M | +6.7% |
| Current Liabilities | $8.5M | -47.9% |
| Total Liabilities | $11.5M | -44.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.6M | +90.3% |
| Capital Expenditures | $8.0M | +7.6% |
| Investing Cash Flow | -$8.8M | -10.1% |
| Financing Cash Flow | -$14.3M | -5.0% |
| Free Cash Flow | $17.6M | +192.5% |
| +11.9% |
| EPS (Basic) | $1.52 | +11.8% |
| EPS (Diluted) | $1.50 | +11.1% |
| Stockholders' Equity |
| $86.8M |
| +21.6% |